TGFB1 and cancer: CD36 is strongly linked to immune regulation, as evidenced by its association with diverse immune infiltrates, enrichment in TGF-β–dominant and inflammatory subtypes, and correlation with key steps of the cancer immune cycle, highlighting its role in remodeling the tumor-immune microenvironment.